Related Experiment Video
Updated: May 28, 2026

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
TRP channel antagonists as potential antitussives.
Megan S Grace1, Eric Dubuis, Mark A Birrell
1Faculty of Medicine, Respiratory Pharmacology, Pharmacology & Toxicology Section, National Heart and Lung Institute, Imperial College London, Exhibition Road, London SW7 2AZ, UK.
Chronic cough, often linked to respiratory diseases, lacks effective treatments. Research suggests Transient Receptor Potential (TRP) channels on airway nerves are key to the cough reflex, offering new therapeutic targets.
Area of Science:
- Respiratory Medicine
- Neuroscience
- Pharmacology
Background:
- Cough is a common, troublesome symptom in various respiratory diseases.
- Chronic cough presents frequently in specialist clinics, yet effective treatments are limited.
- The underlying mechanisms provoking cough are poorly understood.
Purpose of the Study:
- To investigate the role of G-protein-coupled receptors and ion channels in the cough reflex.
- To explore the involvement of Transient Receptor Potential (TRP) channels in cough pathogenesis.
- To support the development of novel therapeutic strategies for chronic cough.
Main Methods:
- Focus on the interaction between G-protein-coupled receptors and ion channels on airway sensory nerves.
- Investigate the role of TRP channels in regulating the afferent pathways of the cough reflex.
- Review current research on the pathogenesis of cough.
Main Results:
- Transient Receptor Potential (TRP) channels are implicated as major regulators of the cough reflex's afferent arm.
- These channels may contribute to the exaggerated cough response seen in disease states.
- Evidence supports TRP channels as targets for novel cough treatments.
Conclusions:
- Understanding TRP channel function in airway nerves is crucial for deciphering cough mechanisms.
- TRP channel inhibitors represent promising, selective therapeutic options for chronic cough.
- Further research into TRP channel modulation could lead to improved treatments for cough-related disorders.
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Cholinergic Antagonists: Pharmacokinetics
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
